
Brii Biosciences Updates Nomination Committee Terms

I'm PortAI, I can summarize articles.
Brii Biosciences Limited has updated the terms of reference for its Nomination Committee, which is responsible for identifying and recommending candidates for the company’s board of directors. The updated guidelines emphasize diversity and independence to enhance board performance and governance. The most recent analyst rating on Brii Biosciences stock is a Hold with a HK$1.50 price target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

